Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Instagram Outage Disrupts Thousands of U.S. Users 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
LOS ANGELES, Sept. 11, 2017 -- Levine Leichtman Capital Partners (“LLCP”), a Los Angeles-based private equity firm, announced that it has partnered with management to acquire Capsa Healthcare (“Capsa” or the “Company”). Capsa is a leading provider of mobile workstations, medication management products, and pharmacy automation solutions for healthcare settings worldwide. The Company’s workflow solutions increase efficiency for over 3,000 customers, including leading health systems, senior care communities and major retail and institutional pharmacies. Capsa is headquartered in Portland, OR and has additional production facilities in Columbus, OH and Agua Prieta, Mexico.
The investment in Capsa will be the first investment from Levine Leichtman Capital Partners VI, L.P. According to Aaron Perlmutter, Partner of LLCP, “We are excited to partner with Andrew Sherrill, CEO, and the rest of the Capsa management team, who have successfully built a market leading company in an attractive segment of the healthcare industry. We are looking forward to working with Andrew and his team to continue providing innovative solutions to a growing and evolving healthcare landscape.”
The Company’s management team, led by Andrew Sherrill, will acquire a meaningful ownership stake in the Company in connection with the transaction. Andrew Sherrill commented, “My team and I are very excited to partner with LLCP as Capsa seeks to enhance its market-leading position across the healthcare ecosystem. LLCP’s experience across sectors including highly-engineered products and healthcare services – the intersection of which Capsa is situated – as well as LLCP’s operational and deal origination resources, will be critical to the continued growth of the Company.”
LLCP was advised by Kirkland & Ellis LLP. Senior financing was provided by Midcap Financial, NewStar Financial and Madison Capital.
About Levine Leichtman Capital Partners
LLCP is a Los Angeles, California based private investment firm that has managed approximately $9.0 billion of institutional capital since its inception. LLCP invests in middle market companies located in the United States and Europe. LLCP is currently making new investments through Levine Leichtman Capital Partners VI, L.P., LLCP Lower Middle Market Fund, L.P., Levine Leichtman Capital Partners Private Capital Solutions, L.P., Levine Leichtman Capital Partners Europe, L.P. and LLCP Co-Investment Fund, L.P. LLCP has offices in Los Angeles, New York, Dallas, Chicago, London and The Hague.
Contact: David Wolmer
Phone: 310-275-5335
